ACSL4 and diabetic kidney disease: Mangiferin monosodium salt (MGM) augments GPX4 and FSP1/CoQ10 axis expression, suppresses lipid drivers promoting renal prolapse mediated by ACSL4, mitigates ROS and lipid accumulation, and inhibits ferroptosis in DKD rats.